NCT01219140已完成1 期
A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Trial to Evaluate the Safety and Efficacy of Pomegranate Extract Capsules in Post-Menopausal Subjects With Decreased Bone Mineral Density
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 64
- 试验地点
- 2
- 主要终点
- Biomarkers
研究概览
简要总结
Treatment of post-menopausal subjects (with decreased bone mineral density) with pomegranate extract capsules will produce statistically significant changes in biomarkers for bone resorption and formation when compared to subjects receiving placebo.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 45 Years 至 65 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Postmenopausal women (having had their last menstrual period within the past 15 years and an appropriate serum FSH value) 45-65 years of age;
- •The subject must have a T score of -1 to -2.5 at the lumbar spine or proximal femur;
- •All clinical safety laboratory values at screening and randomization must be either within the reference range or be determined by the investigator and the sponsor to be abnormal, but not clinically significant;
- •The patient must have provided written informed consent.
排除标准
- •The subject has any of the following conditions: connective tissue disease, history of clinically significant renal, hepatic pulmonary, cardiovascular, cerebrovascular, gastrointestinal, metabolic, hematological, endocrinological, urological, immunological, neurologic or psychiatric disorders, unless approved by the sponsor on a case by case basis;
- •The subject has a positive test result for Hepatitis B surface antigen or antibody to hepatitis C virus at Screening;
- •The subject has a known history of infection with the human immunodeficiency virus (HIV); -
- •The subject has used bisphosphonate or fluoride therapy within the past 12 or 24 months, respectively;
- •The subject has used denosumab within the past 24 months;
- •The subject has used tibolone, parathyroid hormone (or any of its derivatives), systemic glucocorticoids or inhaled glucocorticoids, anabolic steroids or testosterone within the past 6 months;
- •The subject has used estrogens, selective estrogen receptor modulators, calcitonin or calcitriol within the past 3 months;
- •The subject has hyperparathyroidism, hypoparathyroidsim, hyperthyroidism, hypothyroidism, hypocalcemia, rheumatoid arthritis, paget's disease of bone, osteomalacia;
- •The subject has had a bone fracture within the past year;
- •The subject has acute or chronic disease requiring frequent changes in medications or dosages of chronic therapy;
- •A history of alcoholism within the last 2 years or a current history of imbibing 3 or more units of alcohol per day. (1 unit is equivalent to 1 glass of wine, 1 pint of beer, or 1 shot of hard liquor);
- •The subject has participated in another study with an investigational drug or device during the 30 days prior to study entry;
- •The subject has a condition interfering with his ability to provide informed consent or comply with study instructions, or the patient has a condition, which might confound the interpretation of the study result;
- •The subject has a condition endangering herself if she were to participate in this trial
结局指标
主要结局
Biomarkers
时间窗: Throughout study
To evaluate the impact of pomegranate extract capsules on urinary N-terminal telopeptide (NTX) and serum procollagen type 1 amino-terminal propeptide (P1NP), in post-menopausal women with decreased bone mineral density
次要结局
- Number of Participants with Adverse Events as a Measure of Safety and Tolerability(Throughout study)
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
不适用
Effects of Polyphenols of Pomegranate Fruit Peel Extract on Inflammation and Oxidative Stress in Metabolic SyndromeMetabolic SyndromeNCT05915117University of Banja Luka60
终止
2 期
The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot StudyHeart FailureCardiomyopathyNCT01102140Jennifer Cowger , MD, MS20
已完成
不适用
Study of the effect of pomegranate seed in diabetesDiabetes type 2.Type 2 diabetes mellitusIRCT20170125032171N2Yazd University of Medical Sciences60
已完成
不适用
Effect of pomegranate supplement on Rheumatoid Arthritis patientsCondition 1: Rheumatoid arthritis. Condition 2: Rheumatoid arthritis.Other rheumatoid arthritisSeropositive rheumatoid arthritisIRCT201202183236N2Vice chancellor for research OF Shiraz university of medical sciences50
已完成
不适用
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before ProstatectomyProstate CancerNCT00719030Jonsson Comprehensive Cancer Center25